annual CFI:
-$32.63M-$166.12M(-124.44%)Summary
- As of today (June 2, 2025), TXG annual cash flow from investing activities is -$32.63 million, with the most recent change of -$166.12 million (-124.44%) on December 31, 2024.
- During the last 3 years, TXG annual CFI has risen by +$74.10 million (+69.43%).
- TXG annual CFI is now -124.44% below its all-time high of $133.49 million, reached on December 31, 2023.
Performance
TXG Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$1.89M+$49.70M(+96.33%)Summary
- As of today (June 2, 2025), TXG quarterly cash flow from investing activities is -$1.89 million, with the most recent change of +$49.70 million (+96.33%) on March 31, 2025.
- Over the past year, TXG quarterly CFI has dropped by -$12.53 million (-117.80%).
- TXG quarterly CFI is now -101.58% below its all-time high of $119.96 million, reached on March 31, 2023.
Performance
TXG quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$45.16M-$12.53M(-38.38%)Summary
- As of today (June 2, 2025), TXG TTM cash flow from investing activities is -$45.16 million, with the most recent change of -$12.53 million (-38.38%) on March 31, 2025.
- Over the past year, TXG TTM CFI has dropped by -$69.32 million (-286.84%).
- TXG TTM CFI is now -133.83% below its all-time high of $133.49 million, reached on December 31, 2023.
Performance
TXG TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TXG Cash from investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -124.4% | -117.8% | -286.8% |
3 y3 years | +69.4% | +99.3% | +85.9% |
5 y5 years | +23.7% | +76.6% | -8.9% |
TXG Cash from investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -124.4% | +90.7% | -101.6% | +99.3% | -133.8% | +87.1% |
5 y | 5-year | -124.4% | +90.7% | -101.6% | +99.3% | -133.8% | +87.1% |
alltime | all time | -124.4% | +90.7% | -101.6% | +99.3% | -133.8% | +87.1% |
TXG Cash from investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$1.89M(-96.3%) | -$45.16M(+38.4%) |
Dec 2024 | -$32.63M(-124.4%) | -$51.59M(+1326.0%) | -$32.63M(-201.8%) |
Sep 2024 | - | -$3.62M(-130.3%) | $32.06M(-21.0%) |
Jun 2024 | - | $11.95M(+12.4%) | $40.58M(+67.9%) |
Mar 2024 | - | $10.63M(-18.8%) | $24.17M(-81.9%) |
Dec 2023 | $133.49M(-138.0%) | $13.10M(+167.3%) | $133.49M(+53.0%) |
Sep 2023 | - | $4.90M(-209.8%) | $87.22M(+75.5%) |
Jun 2023 | - | -$4.46M(-103.7%) | $49.69M(+86.6%) |
Mar 2023 | - | $119.96M(-461.6%) | $26.63M(-107.6%) |
Dec 2022 | -$350.89M(+228.8%) | -$33.17M(+1.7%) | -$350.89M(+1.6%) |
Sep 2022 | - | -$32.63M(+18.5%) | -$345.33M(+3.7%) |
Jun 2022 | - | -$27.53M(-89.3%) | -$332.93M(+4.1%) |
Mar 2022 | - | -$257.56M(+832.6%) | -$319.97M(+199.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$106.73M(+178.0%) | -$27.62M(+36.5%) | -$106.73M(+5.3%) |
Sep 2021 | - | -$20.23M(+38.8%) | -$101.38M(+22.9%) |
Jun 2021 | - | -$14.57M(-67.1%) | -$82.46M(+10.5%) |
Mar 2021 | - | -$44.32M(+99.0%) | -$74.63M(+94.4%) |
Dec 2020 | -$38.39M(-10.2%) | -$22.27M(+1599.7%) | -$38.39M(+69.1%) |
Sep 2020 | - | -$1.31M(-80.6%) | -$22.71M(-35.3%) |
Jun 2020 | - | -$6.74M(-16.6%) | -$35.08M(-15.4%) |
Mar 2020 | - | -$8.08M(+22.8%) | -$41.48M(-3.0%) |
Dec 2019 | -$42.77M(+537.5%) | -$6.58M(-51.9%) | -$42.77M(+18.2%) |
Sep 2019 | - | -$13.68M(+4.1%) | -$36.19M(+60.8%) |
Jun 2019 | - | -$13.14M(+40.3%) | -$22.51M(+140.3%) |
Mar 2019 | - | -$9.37M | -$9.37M |
Dec 2018 | -$6.71M(+78.6%) | - | - |
Dec 2017 | -$3.76M | - | - |
FAQ
- What is 10x Genomics annual cash flow from investing activities?
- What is the all time high annual CFI for 10x Genomics?
- What is 10x Genomics annual CFI year-on-year change?
- What is 10x Genomics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for 10x Genomics?
- What is 10x Genomics quarterly CFI year-on-year change?
- What is 10x Genomics TTM cash flow from investing activities?
- What is the all time high TTM CFI for 10x Genomics?
- What is 10x Genomics TTM CFI year-on-year change?
What is 10x Genomics annual cash flow from investing activities?
The current annual CFI of TXG is -$32.63M
What is the all time high annual CFI for 10x Genomics?
10x Genomics all-time high annual cash flow from investing activities is $133.49M
What is 10x Genomics annual CFI year-on-year change?
Over the past year, TXG annual cash flow from investing activities has changed by -$166.12M (-124.44%)
What is 10x Genomics quarterly cash flow from investing activities?
The current quarterly CFI of TXG is -$1.89M
What is the all time high quarterly CFI for 10x Genomics?
10x Genomics all-time high quarterly cash flow from investing activities is $119.96M
What is 10x Genomics quarterly CFI year-on-year change?
Over the past year, TXG quarterly cash flow from investing activities has changed by -$12.53M (-117.80%)
What is 10x Genomics TTM cash flow from investing activities?
The current TTM CFI of TXG is -$45.16M
What is the all time high TTM CFI for 10x Genomics?
10x Genomics all-time high TTM cash flow from investing activities is $133.49M
What is 10x Genomics TTM CFI year-on-year change?
Over the past year, TXG TTM cash flow from investing activities has changed by -$69.32M (-286.84%)